219 related articles for article (PubMed ID: 25482743)
1. Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014.
Chen SC; Sorrell TC; Chang CC; Paige EK; Bryant PA; Slavin MA
Intern Med J; 2014 Dec; 44(12b):1315-32. PubMed ID: 25482743
[TBL] [Abstract][Full Text] [Related]
2. Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014.
Blyth CC; Gilroy NM; Guy SD; Chambers ST; Cheong EY; Gottlieb T; McGuinness SL; Thursky KA
Intern Med J; 2014 Dec; 44(12b):1333-49. PubMed ID: 25482744
[TBL] [Abstract][Full Text] [Related]
3. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014.
Cooley L; Dendle C; Wolf J; Teh BW; Chen SC; Boutlis C; Thursky KA
Intern Med J; 2014 Dec; 44(12b):1350-63. PubMed ID: 25482745
[TBL] [Abstract][Full Text] [Related]
4. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia.
Schmiedel Y; Zimmerli S
Swiss Med Wkly; 2016; 146():w14281. PubMed ID: 26901377
[TBL] [Abstract][Full Text] [Related]
5. Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014.
Slavin MA; Thursky KA; Worth LJ; Chang CC; Morrissey CO; Blyth CC; Chen SC; Szer J
Intern Med J; 2014 Dec; 44(12b):1267-76. PubMed ID: 25482739
[TBL] [Abstract][Full Text] [Related]
6. Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014.
Morrissey CO; Gilroy NM; Macesic N; Walker P; Ananda-Rajah M; May M; Heath CH; Grigg A; Bardy PG; Kwan J; Kirsa SW; Slavin M; Gottlieb T; Chen S
Intern Med J; 2014 Dec; 44(12b):1298-314. PubMed ID: 25482742
[TBL] [Abstract][Full Text] [Related]
7. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
[TBL] [Abstract][Full Text] [Related]
8. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
9. Micafungin use in children.
Emiroglu M
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):821-34. PubMed ID: 21905789
[TBL] [Abstract][Full Text] [Related]
10. Fungal infections in the ICU: advances in treatment and diagnosis.
De Pascale G; Tumbarello M
Curr Opin Crit Care; 2015 Oct; 21(5):421-9. PubMed ID: 26165502
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of invasive fungal infections in immunocompromised children.
Dornbusch HJ; Groll A; Walsh TJ
Clin Microbiol Infect; 2010 Sep; 16(9):1328-34. PubMed ID: 20678175
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic Fungal Infections in Critical Care Units.
Garbee DD; Pierce SS; Manning J
Crit Care Nurs Clin North Am; 2017 Mar; 29(1):67-79. PubMed ID: 28160958
[TBL] [Abstract][Full Text] [Related]
13. Pharmacist review of high-risk haematology outpatients to improve appropriateness of antifungal prophylaxis.
Reslan Z; Lindsay J; Kerridge I; Gellatly R
Int J Clin Pharm; 2020 Dec; 42(6):1412-1418. PubMed ID: 33009604
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and management of fungal infections and pneumocystis pneumonitis in pediatric cancer patients].
Groll AH; Ritter J
Klin Padiatr; 2005 Nov; 217 Suppl 1():S37-66. PubMed ID: 16288352
[TBL] [Abstract][Full Text] [Related]
15. EPICO PROJECT. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non- neutropenic critically ill adult patients.
Epico Project Group
Rev Esp Quimioter; 2013 Jun; 26(2):131-50. PubMed ID: 23817652
[TBL] [Abstract][Full Text] [Related]
16. Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.
Fleming S; Yannakou CK; Haeusler GM; Clark J; Grigg A; Heath CH; Bajel A; van Hal SJ; Chen SC; Milliken ST; Morrissey CO; Tam CS; Szer J; Weinkove R; Slavin MA
Intern Med J; 2014 Dec; 44(12b):1283-97. PubMed ID: 25482741
[TBL] [Abstract][Full Text] [Related]
17. Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand.
van Hal SJ; Gilroy NM; Morrissey CO; Worth LJ; Szer J; Tam CS; Chen SC; Thursky KA; Slavin MA
Intern Med J; 2014 Dec; 44(12b):1277-82. PubMed ID: 25482740
[TBL] [Abstract][Full Text] [Related]
18. Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.
Bailly S; Bouadma L; Azoulay E; Orgeas MG; Adrie C; Souweine B; Schwebel C; Maubon D; Hamidfar-Roy R; Darmon M; Wolff M; Cornet M; Timsit JF
Am J Respir Crit Care Med; 2015 May; 191(10):1139-46. PubMed ID: 25780856
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous cryptococcosis during infliximab therapy.
Chiriac A; Mares M; Mihaila D; Solovan C; Moldovan C; Stolnicu S; Hagen F
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27637071
[No Abstract] [Full Text] [Related]
20. Changing epidemiology of systemic fungal infections.
Richardson M; Lass-Flörl C
Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
